Document is current

Any future updates will be listed below

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

Crossref DOI link: https://doi.org/10.1007/s12325-021-01825-4

Published Online: 2021-07-17

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark